Futura Medical plc (LON:FUM – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 0.94 and traded as low as GBX 0.34. Futura Medical shares last traded at GBX 0.34, with a volume of 2,033,750 shares traded.
Futura Medical Price Performance
The company’s fifty day moving average is GBX 0.53 and its 200-day moving average is GBX 0.94. The company has a market capitalization of £2.44 million, a PE ratio of -0.15 and a beta of 0.02.
Futura Medical (LON:FUM – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. The company had revenue of GBX 170 million during the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. Equities research analysts forecast that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.
Futura Medical Company Profile
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.
Further Reading
- Five stocks we like better than Futura Medical
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
